[14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study

Inclusion Criteria: * males * any ethnic origin * age 35-60 * BMI 18-35 kg/m2 * generally in good health * signed informed consent Exclusion Criteria: * subjects or subjects partners not willing to use appropriate contraception * subjects who have received prescribed systemic or topical medication within 14 days of dosing * subjects who have used non-prescribed systemic or topical medication within 7 days of dosing * subjects who have received any medication incl. St. Johns Worth within 30 days of dose administration. * subjects participating in clinical trial currently or within past 3 months. * recent blood donation * history of drug allergy or clinically significant allergic disease * BP and pulse outside reference range * high consumption of alcohol * high consumption og tobacco * clinically significant disorder or clinically significant disease within 4 weeks of dosing. * serum hepatitis, HIV or abnormal ECG * subjects exposed to radiation as a result of their occupation * subjects who have received radiolabelled material within 12 months * subjects earlier taken part in the study or withdrawn from study ot not suitable for enrolment according to investigator.